Fertility Test Market Expected to Reach $0.84 Billion by 2028

According to a new report published by Allied Market Research, titled, “Fertility Test Market by Product, Mode of Purchase, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2020–2028," the global fertility test market size was valued at $0.42 billion in 2020, and is projected to reach $0.84 billion by 2028, registering a CAGR of 7.8%. Fertility testing is a medical and physical testing assessment that tests the ability to naturally conceive. Growth in age is one of the factors that can affect fertility, so women and men who are 35 or older should consider fertility testing if they are unable to conceive even after six months of trying. The process of fertility testing involves the analysis of medical history, blood test, and minimally invasive procedures. It involves mainly the ovulation test by the detection of hormones such as luteinizing hormone or progesterone hormone in blood, urine, or saliva. The tests for men include semen analysis for normal sperm count. 

On the other hand, the fertility testing uses the ovulation prediction tests. These test kits use test strips for the detection of specific hormones. These tests are mostly performed at home recently using the user-friendly test kits. These tests are used by women to determine the time in the monthly cycle when getting pregnant is most likely. 

Rise in the prevalence of diseases such as Polycystic Ovary Syndrome (PCOS), increase in number of first-time pregnancies in women, declining fertility rates across the globe, growth in awareness regarding fertility testing in both developed and developing countries, and launch of technologically advanced products with high accuracy are the major factors that drive the growth of the fertility test market. Moreover, growth in preference for confidentially and accessibility of test results and rapid outcomes of diagnosis are other factors that attribute to the growth of the fertility test market. However, unproven accuracy of ovulation monitors in PCOS/PCOD patients and high cost of fertility testing monitors are expected to hinder the growth of the market.

The global fertility test market is segmented on the basis of type of product, mode of purchase, application, end user, and region. By product, the market is divided into ovulation prediction kits, fertility monitors, and male fertility testing products. The fertility monitors segment is further divided into urine-based ovulation kits, saliva-based ovulation kits, and other fertility monitors. By mode of purchase, it is bifurcated into OTC-based and prescription-based. By application, it is fragmented into female fertility testing and male fertility testing. By end user, it is bifurcated into home care settings and fertility clinics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

On the basis of product, the fertility test market is classified into ovulation prediction kit, fertility monitors, and male fertility testing products. The fertility monitors segment is further segmented into urine-based ovulation kits, saliva-based ovulation kits, and other fertility monitors. The ovulation prediction kits segment is the major contributor toward the market growth, owing to increase in the use of ovulation prediction kits and easy availability of the over-the-counter test kits for at home testing. On the basis of mode of purchase, the fertility test market is classified into OTC-based and prescription-based. The OTC-based segment is expected to dominate the fertility test market during the forecast year. The high growth and large share are attributed to the easy availability of the over-the-counter testing products for at home fertility testing.

On the basis of application, the fertility test market is segmented into female fertility testing and male fertility testing. In this, the female fertility testing is attributed for the larger market share due to the availability of the wide range of fertility testing products for females, technologically advanced testing kits that predict accurate ovulation date, and reduction in female fertility rates. On the basis of the end user, the fertility test market is segmented into home care settings and fertility clinics. Home care settings is expected to dominate the fertility test market, owing to the shift in the patients toward self-monitoring of healthcare conditions and easy availability of the user-friendly advantage of the at home test products. For instance, the companies are launching the ovulation prediction kits that can be used at home to test the hormonal presence in the saliva or urine needed for the ovulation.

North America is constituted to have highest market share of the fertility test market in 2020, followed by the other sectors. This is attributed to the factors such as high prevalence of infertility and increase in awareness regarding fertility testing among the population and availability of the technologically advanced products. Overall, it is projected that the need for fertility testing in developing and developed regions of North America would rise sharply in the coming years.

Key Findings Of The Study 

• By product, the ovulation prediction kits segment occupied a major share in 2020, and is expected to maintain the trend throughout the forecast period. 
• The OTC-based segment is expected to grow with a CAGR of 8.0% from 2021 to 2028. 
• Female fertility testing segment held a major share in the global market in 2020, and is expected to retain it throughout the forecast period. 
• Asia-Pacific is expected to be the fastest growing region, registering a CAGR of 8.7% during the forecast period.

The key players operating in the global fertility test market include Church & Dwight Co. Inc., Fairhaven Health LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products Inc., Prestige Brands Holdings Inc., Quidel Corporation, Abbott Laboratories, UEBE Medical, and Advacare Pharma.